Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £26.43 billion [US$40.11 billion]
of which 81%
(39.76 billion Euro [US$51.04 billion]
of which 29%
was Material Science), and
based in France
(34.95 billion Euro [US$44.86 billion]
of which 83%
Roche Holding Aktiengesellschaft reported sales of 45.50 billion Swiss Francs (US$46.81 billion)
December of 2012.
increase of 7.0%
versus 2011, when the company's sales were 42.53 billion Swiss Francs.
Despite this increase, sales are still
below the level achieved in 2010, when Roche Holding Aktiengesellschaft
reported sales of 47.47 billion Swiss Francs.
The sales level in 2012 was fairly close to the level five years ago: in 2007, Roche Holding Aktiengesellschaft had sales
of 46.13 billion Swiss Francs.
Sales of Pharmaceuticals saw an increase
7.4% in 2012, from
32.79 billion Swiss Francs to 35.23 billion Swiss Francs.